NDA 072123 describes DROPERIDOL, which is a drug marketed by
Abraxis Pharm,
Am Regent,
Astrazeneca,
Hikma,
Hospira,
Igi Labs Inc,
Luitpold,
Smith And Nephew,
Solopak, and
Watson Labs, and is included in eighteen NDAs. It is available from
two suppliers. Additional details are available on the
DROPERIDOL profile page.
The generic ingredient in DROPERIDOL is
droperidol. There are five
drug master file entries for this compound. Two
suppliers are listed for this compound. Additional details are available on the
droperidol profile page.